Investors unimpressed as Aspen sells baby formula business
Loading player...
Stephen Saad – CEO, Aspen Pharmacare
Other recent episodes
[TOP STORY] Court ruling opens door for previously rejected RAF claims
‘It gives claimants a new chance now until 30 September of this year to resubmit claims which were previously unlawfully rejected,’ says Kirstie Haslam, partner at DSC Attorneys.
Unpredictable skies threaten SA’s agricultural outlook
Hormuz disruption fast-tracks the age of real-time trade data. Economic freedom at risk as SA’s factories fall silent. Thousands of RAF claims could restart after landmark ruling.
[TOP STORY] Xenophobic rhetoric risks escalating into organised violence
‘It’s having implications for business. I think that business certainly needs to make its voice heard more loudly,’ says Ferial Haffajee, associate editor at the Daily Maverick.
Cape Town tests car-lite future with Bree street experiment
Xenophobic marches surge as UN sounds alarm. From Everest to SA: Are our warning systems working? And why the NHI cannot work while staffing and system gaps remain unresolved.
[TOP STORY] GEPF eyes infrastructure to boost returns in uncertain climate
‘With the war in Iran, in the first week it wiped out R200 billion from our investment. So clearly it means that we have to adapt, given the developments,’ says Frans Baleni, chair of the Government Employees Pension Fund.